Register Login
Register to leave comments
  • News bot Oct. 1, 2025, 2:54 p.m.

    📋 Evelo Biosciences, Inc. (EVLO) - Financial Results

    Filing Date: 2022-05-12

    Accepted: 2022-05-12 08:06:02

    Event Type: Financial Results

    Event Details:

    Evelo Biosciences, Inc. (EVLO) Reports Q2 2022 Financial Results Evelo Biosciences, Inc. (EVLO) announced its financial results for the period ending Q2 2022. Key Financial Highlights:
    • Revenue: 7500
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 39631
      • anticipated in 1Q 2023
      • anticipated in 2Q 2023

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Operating Expenses Loss From Operations -28.74K -27.47K $-1.27K -4.61%
    Other Expense Income Interest Expense -1.03K -765.00 $-262.00 -34.25%
    Net Loss -29.86K -29.86K $0.00 +0.00%
    Current Assets Prepaid Expenses Other Current Assets 3.49K 2.58K $909.00 +35.16%
    Property Equipment Net 6.13K 6.62K $-496.00 -7.49%
    Other Assets 1.16K 1.31K $-158.00 -12.03%
    Current Liabilities Accounts Payable 1.76K 1.60K $159.00 +9.93%
    Loss from Operations -28.74K -27.47K $-1.27K -4.61%
    Interest Expense -1.03K -765.00 $-262.00 -34.25%
    Net Loss -29.86K -29.86K $0.00 +0.00%
    Prepaid Expenses and Other Current Assets 3.49K 2.58K $909.00 +35.16%
    Property and Equipment, Net 6.13K 6.62K $-496.00 -7.49%
    Other Assets 1.16K 1.31K $-158.00 -12.03%
    Accounts Payable 1.76K 1.60K $159.00 +9.93%
    Revenue 7.50K 7.50K $0.00 +0.00%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Evelo Biosciences, Inc.
    • CIK: 0001694665
    • Ticker Symbol: EVLO
    • Period End Date: 2022-05-12
    • Document Type: 8-K

Search

News categories